-
1
Assessment of efficacy and safety of imatinib as an adjunct host-targeted therapy for parasite clearance in chloroquine-resistant malaria: a prospective case control study
Published 2025-01-01Subjects: “…Chloroquine-resistant malaria…”
Get full text
Article